Guardant Health IncNASDAQ:GH
- LAST PRICE36.7700
- TODAY'S CHANGE (%)2.0200 (5.8129%)
- Bid / Lots36.0000/ 2
- Ask / Lots41.0000/ 1
- Open / Previous Close35.6500 / 34.7500
- Day Range
- 52 Week Range
- Volume1,626,041
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GH |
|---|---|---|
| 09:32 ET | 14172 | 35.88 |
| 09:34 ET | 1650 | 36.18 |
| 09:36 ET | 11411 | 35.28 |
| 09:38 ET | 2000 | 35.57 |
| 09:39 ET | 1406 | 35.64 |
| 09:41 ET | 1236 | 35.39 |
| 09:43 ET | 3311 | 35.58 |
| 09:45 ET | 3757 | 35.67 |
| 09:48 ET | 2150 | 35.47 |
| 09:50 ET | 4086 | 35.48 |
| 09:52 ET | 2206 | 35.48 |
| 09:54 ET | 2720 | 35.7 |
| 09:56 ET | 4850 | 35.57 |
| 09:57 ET | 2278 | 35.83 |
| 09:59 ET | 2625 | 36.06 |
| 10:01 ET | 4998 | 35.8 |
| 10:03 ET | 5466 | 36.1 |
| 10:06 ET | 5517 | 36.06 |
| 10:08 ET | 5070 | 35.71 |
| 10:10 ET | 11392 | 35.68 |
| 10:12 ET | 19348 | 35.875 |
| 10:14 ET | 3277 | 35.77 |
| 10:15 ET | 154253 | 35.965 |
| 10:17 ET | 1474 | 35.95 |
| 10:19 ET | 1461 | 35.88 |
| 10:21 ET | 2800 | 35.66 |
| 10:24 ET | 2651 | 35.96 |
| 10:26 ET | 5677 | 36.16 |
| 10:28 ET | 5197 | 36.47 |
| 10:30 ET | 4774 | 36.81 |
| 10:32 ET | 5486 | 36.65 |
| 10:33 ET | 5570 | 36.47 |
| 10:35 ET | 2871 | 36.355 |
| 10:37 ET | 1050 | 36.28 |
| 10:39 ET | 7995 | 36.035 |
| 10:42 ET | 2345 | 35.99 |
| 10:44 ET | 1452 | 36.02 |
| 10:46 ET | 2713 | 36.015 |
| 10:48 ET | 1701 | 35.81 |
| 10:50 ET | 3771 | 35.88 |
| 10:51 ET | 2041 | 35.62 |
| 10:53 ET | 1268 | 35.5 |
| 10:55 ET | 2537 | 35.65 |
| 10:57 ET | 4099 | 35.475 |
| 11:00 ET | 1557 | 35.48 |
| 11:02 ET | 1202 | 35.53 |
| 11:04 ET | 1307 | 35.47 |
| 11:06 ET | 1774 | 35.4368 |
| 11:08 ET | 20116 | 35.31 |
| 11:09 ET | 4022 | 35.26 |
| 11:11 ET | 2274 | 35.05 |
| 11:13 ET | 2614 | 34.97 |
| 11:15 ET | 1106 | 34.8601 |
| 11:18 ET | 714 | 34.82 |
| 11:20 ET | 1539 | 34.84 |
| 11:22 ET | 2132 | 34.835 |
| 11:24 ET | 2465 | 34.73 |
| 11:26 ET | 4267 | 34.86 |
| 11:27 ET | 2554 | 34.915 |
| 11:29 ET | 1300 | 34.78 |
| 11:31 ET | 2073 | 34.92 |
| 11:33 ET | 1731 | 34.83 |
| 11:36 ET | 2846 | 34.71 |
| 11:38 ET | 3064 | 34.61 |
| 11:40 ET | 7231 | 34.57 |
| 11:42 ET | 4848 | 34.51 |
| 11:44 ET | 100 | 34.65 |
| 11:45 ET | 1942 | 34.68 |
| 11:47 ET | 1591 | 34.75 |
| 11:49 ET | 300 | 34.73 |
| 11:51 ET | 1875 | 34.64 |
| 11:54 ET | 3015 | 34.57 |
| 11:56 ET | 1300 | 34.51 |
| 11:58 ET | 2100 | 34.47 |
| 12:00 ET | 2293 | 34.4 |
| 12:02 ET | 700 | 34.38 |
| 12:03 ET | 1500 | 34.56 |
| 12:05 ET | 5990 | 34.49 |
| 12:07 ET | 4242 | 34.45 |
| 12:09 ET | 1716 | 34.28 |
| 12:12 ET | 2195 | 34.26 |
| 12:14 ET | 925 | 34.37 |
| 12:16 ET | 2593 | 34.41 |
| 12:18 ET | 1016 | 34.26 |
| 12:20 ET | 3295 | 34.27 |
| 12:21 ET | 2152 | 34.4406 |
| 12:23 ET | 1108 | 34.495 |
| 12:25 ET | 1300 | 34.49 |
| 12:27 ET | 1400 | 34.3692 |
| 12:30 ET | 1300 | 34.43 |
| 12:32 ET | 1171 | 34.42 |
| 12:34 ET | 1936 | 34.45 |
| 12:36 ET | 6092 | 34.39 |
| 12:38 ET | 2441 | 34.34 |
| 12:39 ET | 1867 | 34.22 |
| 12:41 ET | 920 | 34.18 |
| 12:43 ET | 1803 | 34.1 |
| 12:45 ET | 2000 | 34.03 |
| 12:48 ET | 2070 | 34.03 |
| 12:50 ET | 2335 | 34.17 |
| 12:52 ET | 3033 | 34.07 |
| 12:54 ET | 3399 | 34 |
| 12:56 ET | 2143 | 34.05 |
| 12:57 ET | 2600 | 34.03 |
| 12:59 ET | 4001 | 34.0605 |
| 01:01 ET | 1756 | 33.92 |
| 01:03 ET | 2738 | 33.85 |
| 01:06 ET | 1042 | 33.89 |
| 01:08 ET | 1663 | 33.89 |
| 01:10 ET | 3441 | 33.75 |
| 01:12 ET | 800 | 33.73 |
| 01:14 ET | 2863 | 33.72 |
| 01:15 ET | 450 | 33.81 |
| 01:17 ET | 1200 | 33.75 |
| 01:19 ET | 2100 | 33.75 |
| 01:21 ET | 1928 | 33.775 |
| 01:24 ET | 6919 | 33.715 |
| 01:26 ET | 1224 | 33.7 |
| 01:28 ET | 2900 | 33.7 |
| 01:30 ET | 900 | 33.64 |
| 01:32 ET | 1766 | 33.895 |
| 01:33 ET | 2090 | 34.08 |
| 01:35 ET | 1300 | 34.13 |
| 01:37 ET | 3437 | 34.31 |
| 01:39 ET | 2538 | 34.36 |
| 01:42 ET | 3623 | 34.27 |
| 01:44 ET | 2300 | 34.31 |
| 01:46 ET | 5251 | 34.28 |
| 01:48 ET | 3138 | 34.22 |
| 01:50 ET | 3035 | 34.16 |
| 01:51 ET | 4539 | 34.07 |
| 01:53 ET | 2527 | 34.315 |
| 01:55 ET | 4507 | 34.46 |
| 01:57 ET | 2952 | 34.62 |
| 02:00 ET | 3115 | 34.65 |
| 02:02 ET | 1635 | 34.66 |
| 02:04 ET | 3599 | 34.65 |
| 02:06 ET | 1400 | 34.52 |
| 02:08 ET | 800 | 34.37 |
| 02:09 ET | 2428 | 34.53 |
| 02:11 ET | 2500 | 34.52 |
| 02:13 ET | 1743 | 34.67 |
| 02:15 ET | 2445 | 34.79 |
| 02:18 ET | 2920 | 34.61 |
| 02:20 ET | 12652 | 34.78 |
| 02:22 ET | 1701 | 34.635 |
| 02:24 ET | 2473 | 34.8 |
| 02:26 ET | 5301 | 34.775 |
| 02:27 ET | 2600 | 34.825 |
| 02:29 ET | 6096 | 34.89 |
| 02:31 ET | 21199 | 34.75 |
| 02:33 ET | 2785 | 34.735 |
| 02:36 ET | 1163 | 34.79 |
| 02:38 ET | 4600 | 34.99 |
| 02:40 ET | 5278 | 35.06 |
| 02:42 ET | 4434 | 35.17 |
| 02:44 ET | 2080 | 35.27 |
| 02:45 ET | 5399 | 35.34 |
| 02:47 ET | 3930 | 35.48 |
| 02:49 ET | 2500 | 35.4 |
| 02:51 ET | 2973 | 35.43 |
| 02:54 ET | 3013 | 35.76 |
| 02:56 ET | 2370 | 35.73 |
| 02:58 ET | 11089 | 35.6 |
| 03:00 ET | 8798 | 35.56 |
| 03:02 ET | 6044 | 35.605 |
| 03:03 ET | 5533 | 35.49 |
| 03:05 ET | 6193 | 35.48 |
| 03:07 ET | 4032 | 35.36 |
| 03:09 ET | 3417 | 35.51 |
| 03:12 ET | 3933 | 35.614 |
| 03:14 ET | 2700 | 35.585 |
| 03:16 ET | 4936 | 35.65 |
| 03:18 ET | 1547 | 35.72 |
| 03:20 ET | 4487 | 35.785 |
| 03:21 ET | 4217 | 35.99 |
| 03:23 ET | 7548 | 36.045 |
| 03:25 ET | 5100 | 36.02 |
| 03:27 ET | 7300 | 36.15 |
| 03:30 ET | 8571 | 36.3095 |
| 03:32 ET | 7270 | 36.21 |
| 03:34 ET | 8347 | 36.325 |
| 03:36 ET | 16762 | 36.355 |
| 03:38 ET | 8466 | 36.53 |
| 03:39 ET | 13680 | 36.55 |
| 03:41 ET | 9488 | 36.75 |
| 03:43 ET | 15059 | 36.8 |
| 03:45 ET | 12461 | 36.62 |
| 03:48 ET | 29194 | 36.64 |
| 03:50 ET | 13282 | 36.49 |
| 03:52 ET | 18118 | 36.58 |
| 03:54 ET | 24667 | 36.71 |
| 03:56 ET | 35641 | 36.84 |
| 03:57 ET | 64698 | 36.83 |
| 03:59 ET | 213263 | 36.77 |
Yesterday
BRIEF-Guardant Health Presents New Data Showing Blood Test Accuracy In Detecting Colorectal Cancer In Study At Digestive Disease Week 2022, from 3:04AM ET on Saturday May 21, 2022 by Thomson Reuters
3:04AM ET on Saturday May 21, 2022 by Thomson ReutersGuardant Health Presents New Data Showing Blood Test Accuracy in Detecting Colorectal Cancer in First-of-its Kind Prospective Study at Digestive Disease Week 2022, from 3:01AM ET on Saturday May 21, 2022 by Business Wire
3:01AM ET on Saturday May 21, 2022 by Business Wire
May 9, 2022
--JPMorgan Adjusts Price Target for Guardant Health to $125 From $150, Maintains Overweight Rating, from 12:44PM ET on Monday May 09, 2022 by MT Newswires
12:44PM ET on Monday May 09, 2022 by MT Newswires--Morgan Stanley Lowers Guardant Health's Price Target to $85 From $120, Maintains Overweight Rating, from 12:42PM ET on Monday May 09, 2022 by MT Newswires
12:42PM ET on Monday May 09, 2022 by MT Newswires
May 6, 2022
Guardant Health Shares Drop Following Wider Q1 Non-GAAP Loss But Higher Revenue, from 11:08AM ET on Friday May 06, 2022 by MT Newswires
11:08AM ET on Friday May 06, 2022 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Guardant Health Inc | 3.7B | -8.9x | --- |
Ginkgo Bioworks Holdings Inc | 3.9B | -2.1x | --- |
Ultragenyx Pharmaceutical Inc | 3.4B | -7.1x | --- |
Arrowhead Pharmaceuticals Inc | 3.8B | -33.4x | --- |
CureVac NV | 3.5B | 0.0x | --- |
Zai Lab Ltd | 3.6B | -1.2x | --- |
Company Information
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through the use of its blood-based tests, data sets, and advanced analytics. It has developed its Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced-stage cancer. It also developed its Guardant Reveal liquid biopsy-based test for residual and recurring cancer to address the need for Stage II-II I colorectal cancer. Its Guardant360 test is a molecular diagnostic test measuring 74 cancer-related genes. Its Guardant360 CDx test is a liquid biopsy test measuring 55 cancer-related genes. Its GuardantOMNI test has a broader 500-gene panel, all of which analyze circulating tumor deoxyribonucleic acid (DNA) in the blood. The Company's tests are used by biopharmaceutical companies for a range of applications, including identifying patient populations to accelerate translational science research and clinical trial enrollment, and companion diagnostic.
Contact Information
- Headquarters
- 3000 HANOVER STREETPALO ALTO, CA, United States 94304
- Phone
- 650-290-7575
- Fax
- 302-531-3150
Executives
- Chairman of the Board, Co-Chief Executive Officer
- Helmy Eltoukhy
- President, Co-Chief Executive Officer, Director
- Amirali Talasaz
- Chief Financial Officer
- Michael Bell
- Senior Vice President, General Counsel, Corporate Secretary
- John Saia
- Chief Medical Officer
- Craig Eagle
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
|---|---|
Revenue (TTM) | $391.1M |
Shares Outstanding | 101.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.90 |
EPS | $-4.13 |
Book Value | $6.44 |
P/E Ratio | -8.9x |
Price/Sales (TTM) | 9.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -102.66% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
